标题
Spinal muscular atrophy — insights and challenges in the treatment era
作者
关键词
-
出版物
Nature Reviews Neurology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-14
DOI
10.1038/s41582-020-00413-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Twenty-Five Years of Spinal Muscular Atrophy Research: From Phenotype to Genotype to Therapy, and What Comes Next
- (2020) Brunhilde Wirth et al. Annual Review of Genomics and Human Genetics
- Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen
- (2020) Valeria A. Sansone et al. JOURNAL OF PEDIATRICS
- Overturning the Paradigm of Spinal Muscular Atrophy as just a Motor Neuron Disease
- (2020) Crystal Jing Jing Yeo et al. PEDIATRIC NEUROLOGY
- Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
- (2020) Haiyan Zhou et al. Journal of Cachexia Sarcopenia and Muscle
- Spinal Muscular Atrophy in the Black South African Population: A Matter of Rearrangement?
- (2020) Elana Vorster et al. Frontiers in Genetics
- New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
- (2020) Tai-Heng Chen INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
- (2020) Tim Hagenacker et al. LANCET NEUROLOGY
- Nusinersen in adults with spinal muscular atrophy: new challenges
- (2020) Eugenio Mercuri et al. LANCET NEUROLOGY
- Handlungsempfehlungen zur Gentherapie der spinalen Muskelatrophie mit Onasemnogene Abeparvovec – AVXS-101
- (2020) Andreas Ziegler et al. NERVENARZT
- Progression and prognosis in multiple system atrophy presenting with REM behavior disorder
- (2020) Giulia Giannini et al. NEUROLOGY
- Revised Self-Monitoring Scale
- (2020) Gianina Toller et al. NEUROLOGY
- Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
- (2020) Giuseppe Ronzitti et al. Frontiers in Immunology
- Quality of life of patients with spinal muscular atrophy: a systematic review
- (2019) Erik Landfeldt et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Nusinersen in later-onset spinal muscular atrophy
- (2019) Basil T. Darras et al. NEUROLOGY
- Nusinersen in type 1 spinal muscular atrophy: Twelve‐month real‐world data
- (2019) Marika Pane et al. ANNALS OF NEUROLOGY
- Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy
- (2019) Jacqueline Montes et al. MUSCLE & NERVE
- Discrepancy in redetermination of SMN2 copy numbers in children with SMA
- (2019) David Christof Schorling et al. NEUROLOGY
- Effect of Nusinersen on Respiratory Muscle Function in Different Subtypes of Type 1 Spinal Muscular Atrophy
- (2019) Antonella LoMauro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
- (2019) Darryl C. De Vivo et al. NEUROMUSCULAR DISORDERS
- Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment
- (2019) Daniel M. Ramos et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders
- (2019) Yichen Lee et al. CURRENT PHARMACEUTICAL DESIGN
- Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
- (2019) Karolina Aragon‐Gawinska et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy
- (2019) Sonia Messina et al. NEUROMUSCULAR DISORDERS
- Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1
- (2018) Astrid Pechmann et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remain
- (2018) Charlotte J. Sumner et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
- (2018) Richard S. Finkel et al. NEUROMUSCULAR DISORDERS
- Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
- (2018) Maite Calucho et al. NEUROMUSCULAR DISORDERS
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
- (2018) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy
- (2018) Rachel Salazar et al. Pediatric Physical Therapy
- Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
- (2018) Hasane Ratni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA)
- (2018) Phillip Mongiovi et al. NEUROLOGY
- SMA THERAPIES II AND BIOMARKERS
- (2018) E. Mercuri et al. NEUROMUSCULAR DISORDERS
- SMA THERAPIES II AND BIOMARKERS
- (2018) G. Baranello et al. NEUROMUSCULAR DISORDERS
- Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?
- (2018) Maria Carmela Pera et al. NEUROMUSCULAR DISORDERS
- Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
- (2018) Marloes Stam et al. BMJ Open
- Advances in understanding the role of disease-associated proteins in spinal muscular atrophy
- (2017) Seyyedmohsen Hosseinibarkooie et al. Expert Review of Proteomics
- 6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction
- (2017) Maria Carmela Pera et al. NEUROMUSCULAR DISORDERS
- Longitudinal assessments in discordant twins with SMA
- (2017) Marika Pane et al. NEUROMUSCULAR DISORDERS
- Spinal muscular atrophy: A changing phenotype beyond the clinical trials
- (2017) Eduardo F. Tizzano et al. NEUROMUSCULAR DISORDERS
- Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience
- (2017) Sonia Messina et al. NEUROMUSCULAR DISORDERS
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Salbutamol on Respiratory Muscle Strength in Spinal Muscular Atrophy
- (2017) Sonia Khirani et al. PEDIATRIC NEUROLOGY
- Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
- (2017) Manaswini Sivaramakrishnan et al. Nature Communications
- Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
- (2017) Virginie Mariot et al. Nature Communications
- The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
- (2016) Seyyedmohsen Hosseinibarkooie et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy
- (2016) Amy Pasternak et al. MUSCLE & NERVE
- Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
- (2016) Francesco Catapano et al. Molecular Therapy-Nucleic Acids
- Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study
- (2016) Stephen J. Kolb et al. Annals of Clinical and Translational Neurology
- Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I
- (2015) Brian N. Harding et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands
- (2015) Richard Finkel et al. NEUROMUSCULAR DISORDERS
- Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa
- (2014) Modibo Sangaré et al. ANNALS OF NEUROLOGY
- Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
- (2014) Thomas M. Wishart et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of the ß2-Adrenoceptor Agonist, Albuterol, in a Mouse Model of Anti-MuSK Myasthenia Gravis
- (2014) Nazanin Ghazanfari et al. PLoS One
- The motor neuron response toSMN1deficiency in spinal muscular atrophy
- (2013) Peter B. Kang et al. MUSCLE & NERVE
- Leg muscle function and fatigue during walking in spinal muscular atrophy type 3
- (2013) Jacqueline Montes et al. MUSCLE & NERVE
- Six minute walk test in type III spinal muscular atrophy: A 12month longitudinal study
- (2013) E. Mazzone et al. NEUROMUSCULAR DISORDERS
- Synaptic defects in type I spinal muscular atrophy in human development
- (2012) Rebeca Martínez-Hernández et al. JOURNAL OF PATHOLOGY
- Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3
- (2012) R. I. Wadman et al. NEUROLOGY
- Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I
- (2012) Richard S. Finkel NEUROMUSCULAR DISORDERS
- Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
- (2012) Richard S. Finkel et al. PLoS One
- Spinal Muscular Atrophy
- (2011) Stephen J. Kolb ARCHIVES OF NEUROLOGY
- Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability
- (2011) Eva Also-Rallo et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor
- (2010) S. Bernal et al. JOURNAL OF MEDICAL GENETICS
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy
- (2010) J. Montes et al. NEUROLOGY
- SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
- (2010) Kathryn J. Swoboda et al. PLoS One
- Impaired Synaptic Vesicle Release and Immaturity of Neuromuscular Junctions in Spinal Muscular Atrophy Mice
- (2009) L. Kong et al. JOURNAL OF NEUROSCIENCE
- Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
- (2009) Arthur H. M. Burghes et al. NATURE REVIEWS NEUROSCIENCE
- Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
- (2008) Shingo Kariya et al. HUMAN MOLECULAR GENETICS
- Daily salbutamol in young patients with SMA type II
- (2008) Marika Pane et al. NEUROMUSCULAR DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started